Tianyin Pharmaceutical Inc Co Company Profile (NYSEMKT:TPI)

About Tianyin Pharmaceutical Inc Co

Tianyin Pharmaceutical Inc Co logoTianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company's indirect wholly owned subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd., it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in China. As of June 30, 2013, the Company is manufacturing a range of 58 products approved by the China Food and Drug Administration (CFDA), 24 of which are listed in the National Medical Reimbursement List (NMRL) and 10 are listed in the Essential Drug List (EDL) of the China. The Company's medicines are used in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, dermatology, pediatrics, gastroenterology and orthopedics. The Company markets its products through regional distributors, as well as directly to the hospitals, clinics and pharmacies.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: TPI
  • CUSIP:
Key Metrics:
  • Previous Close: $0.16
  • 50 Day Moving Average: $0.160
  • 200 Day Moving Average: $0.152
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $N/A
Additional Links:

Analyst Ratings

Consensus Ratings for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2013Q1$0.05$15.97 million$14.75 millionViewN/AView Earnings Details
9/27/2013Q313$0.07ViewN/AView Earnings Details
2/14/2013Q2 2013$0.06$18.20 million$17.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/3/2014Guoqing JiangCEOBuy23,725$0.68$16,133.00View SEC Filing  
5/28/2014James Jiayuan TongCFOBuy5,000$0.68$3,400.00View SEC Filing  
3/11/2014James Jiayuan TongCFOBuy3,000$1.07$3,210.00View SEC Filing  
6/26/2013James Jiayuan TongCFOBuy8,600$0.49$4,214.00View SEC Filing  
3/28/2013James Jiayuan TongCFOBuy56,500$0.08$4,520.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
DateHeadline
247wallst.com logo8 IPO Hopefuls for Week of July 18 (NYSEMKT:TPI)
247wallst.com - July 18 at 9:25 AM
seekingalpha.com logoNYSE prepares to delist Tianyin Pharma over failure to file financials (NYSEMKT:TPI)
seekingalpha.com - May 7 at 2:51 PM
finance.yahoo.com logoTianyin Pharmaceutical Co., Inc. (TPI) (NYSEMKT:TPI)
finance.yahoo.com - February 18 at 12:54 PM
feeds.benzinga.com logoWorst Performing Industries For February 3, 2016 (NYSEMKT:TPI)
feeds.benzinga.com - February 3 at 12:33 PM
biz.yahoo.com logoTianyin Pharmaceutical Co., Inc. (NYSEMKT:TPI)
biz.yahoo.com - January 21 at 12:33 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing (NYSEMKT:TPI)
biz.yahoo.com - January 11 at 4:39 PM
finance.yahoo.com logoTPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements (NYSEMKT:TPI)
finance.yahoo.com - January 11 at 4:05 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events (NYSEMKT:TPI)
biz.yahoo.com - December 23 at 2:27 PM
finance.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Financials (NYSEMKT:TPI)
finance.yahoo.com - December 8 at 1:15 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru (NYSEMKT:TPI)
biz.yahoo.com - December 2 at 4:06 PM
finance.yahoo.com logoTPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements (NYSEMKT:TPI)
finance.yahoo.com - December 2 at 4:05 PM
capitalcube.com logoTianyin Pharmaceutical Co., Inc. – Value Analysis (NYSE MKT:TPI) : November 3, 2015 (NYSEMKT:TPI)
www.capitalcube.com - November 3 at 12:08 PM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events (NYSEMKT:TPI)
biz.yahoo.com - October 16 at 10:28 AM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 10-Q/A, Quarterly Report (NYSEMKT:TPI)
biz.yahoo.com - August 20 at 10:58 AM
biz.yahoo.com logoTIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review (NYSEMKT:TPI)
biz.yahoo.com - August 11 at 6:21 AM
finance.yahoo.com logoTPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements (NYSEMKT:TPI)
finance.yahoo.com - July 30 at 4:05 PM

Social


Last Updated on 8/26/2016 by MarketBeat.com Staff